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ess: skgleeson01@hotmSummary The National Lung Health Education Program recommends that primary
care providers perform spirometry tests on cigarette smoking patients 45 years or
older in order to detect airways obstruction and aid smoking cessation efforts
[Ferguson GT, Enright Pl, Buist AS, et al. Office spirometry for lung health assessment
in adults: a consensus statement from the national lung education program. Chest
2000; 117: 1146–61]. An abbreviated forced expiratory maneuver that requires
exhalation for 6 s (FEV6) has recently been proposed as a substitute for forced vital
capacity (FVC) to facilitate performance of such spirometry. We set out to assess the
accuracy of diagnosis of obstruction and abnormal pulmonary function using FEV6 in
comparison to FVC in a community hospital population. One hundred pulmonary
function tests performed at a community hospital were randomly selected and
retrospectively analyzed. Sixty-three of the 100 tests had satisfactory 6-s expiration
and were subject to further analysis. We compared the spirometric interpretation
using Morris predictive equations for FEV1/FVC and Hankison predictive equations for
FEV1/FVC and FEV1/FEV6. The Hankison set of equations is the only published
reference formulas for prediction of FEV6. We found that versus our Morris gold
standard, Hankison based FEV1/FVC interpretation was 100% sensitive and 67%
specific for the diagnosis of obstruction and 100% sensitive and 65% specific for the
diagnosis of any abnormality. The Hankison based FEV1/FEV6 interpretation was 97%
sensitive and 47% specific for diagnosing obstruction and 100% sensitive and 50%
specific for identifying any abnormality versus the Morris FVC based gold standard. InPublished by Elsevier Ltd.
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S. Gleeson et al.1398conclusion, in our hospital based pulmonary function laboratory, FEV6 based
interpretation has excellent sensitivity for detection of spirometric abnormalities.
However, its moderate specificity may hinder its utility as a screening test. Further
testing is necessary to determine its reliability in different patient populations with
less highly trained operators.
& 2005 Published by Elsevier Ltd.Introduction
The National Lung Health Education Program
recommends that primary care providers perform
spirometry tests for patients 45 years or older who
report smoking cigarettes in order to detect
airways obstruction and aid smoking cessation
efforts.1 Standard spirometry requires multiple
forced vital capacity (FVC) maneuvers that end
when the patient exhausts his/her exhalation. The
FVC maneuver can cause patient discomfort and is
poorly reproducible unless the results are expertly
supervised. Recently, an abbreviated forced ex-
piratory maneuver that requires exhalation for only
6 s (FEV6) has been proposed as a substitute for
FVC.2,3 The shorter time may reduce the risk of
syncope and makes it unnecessary to measure low
flows at the end of the maneuver rendering the
spirometer less expensive and easier to use by
inexperienced personnel. This new spirometry,
named office spirometry, utilizes the FEV1/FEV6
rather than FEV1/FVC to detect airway obstruction.
Widespread acceptance of this FEV6 based
spirometry may be hindered by concerns about
generalizability and broader utility. Only one set of
predictive equations for FEV6 exists (Hankison et
al.4), and the validity of these equations as a
substitute for FVC has been shown only in select
laboratories serving large, homogenous referral
populations.2,3 Because of differences based on
population age, height, weight, and ethnicity, the
American Thoracic Society (ATS) recommends vali-
dating predictive equations against a particular
pulmonary function laboratory’s own population. In
addition, comparison of Hankison FVC prediction to
other predictive formulas has not been previously
been undertaken. Presumably, if Hankison’s equa-
tions do not predict FVC accurately in a particular
population, they would be unlikely to predict FEV6
accurately in that population.
Although office spirometry has been chiefly
advocated as a screening tool for obstruction in
smokers, once deployed in the primary care office,
primary physicians may be tempted to use it to
screen for other types of pulmonary disease. The
accuracy of spirometry relying on FEV6 for discern-
ing non-obstructive pulmonary abnormalities hasnot been assessed, so its suitability for broader uses
is unknown.5
In this study, our primary objectives were to
assess the concordance of Hankison FVC based
diagnosis of obstruction to diagnoses generated by
applying the Morris predictive equations5,6 (our lab
standard). We then compared the accuracy of FEV6
based diagnosis to both Morris and Hankison based
FVC diagnosis to detect obstruction in patients
tested in our community hospital pulmonary func-
tion laboratory.
Our secondary objective was to evaluate the
ability of FEV6 based analysis to detect any
abnormality of spirometry diagnosed using FVC
interpretation based on both Morris’ and Hankison’s
equations.Methods
We randomly and retrospectively selected 100
pulmonary function tests performed at a commu-
nity hospital in accordance with ATS standards
between September and October 2001. All spiro-
metry was performed on a Collins GS system with a
Stead-Wells volumetric spirometer operated by
Collins GS Plus/SQL Software version 3.2 with a
DEC Celebris computer.
For patients with 6 s of expiration, the pre-
bronchodilator volume vs. time curve was back
extrapolated to identify the start of test. FEV1 and
FEV6 were determined based on the total volume
exhaled at 1 and 6 s, respectively, from the start of
test point. The best of 3 suitable curves was
evaluated as per ATS criteria, FEV1, FEV6, and FVC
were then hand calculated and adjusted to BTPS.7
Normal values for FEV1, FVC, and FEV1/FVC were
predicted using Morris et al.6 and Hankison5
predicted equations. Normal values for FEV6 and
FEV1/FEV6 were predicted using Hankison predic-
tive equations.
Each spirogram was classified 3 times using Morris
based FEV1/FVC criteria (Morris-FVC), Hankison
based FEV1/FVC criteria (Hankison-FVC), and Han-
kison based FEV1/FEV6 criteria (Hankison-FEV6).
The criteria used were:
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FEV6) 80–100% of predicted and FEV1/FVC (or FEV1/
FEV6)X100% of predicted.
Obstruction: FEV1/FVC (or FEV1/FEV6) o100% of
predicted and FEV1o100% of predicted.
Abnormal: Any spirometry result not classified as
normal. This class includes spirograms diagnosed as
obstructed using the above criteria.
Sensitivity and specificity were calculated utiliz-
ing standard formulas from two-by-two tables.Results
The study population consisted of 46 males and 54
females, median age 63.5 years (range from 22 to
91 years) (Table 1). Our population was primarily
Caucasian. Eighteen out of the 100 patients expired
for greater than 8 s, and 45 patients expired for
6–8 s. Thirty-seven patients exhaled for less than 6 s
and, therefore, did not meet end of test criteria forTable 1 Demographic characteristics of the
investigated population.
Demographics Category Statistics
Sex Male 46 (46%)
Female 54 (54%)
Race Caucasian 92 (92%)
African-American 8 (8%)
Age Median 63 years
Range 22–91 years
Height Male Median 175 cm
Range 150–190 cm
Female Median 160 cm
Range 137–180 cm
Weight Male Median 83 kg
Range 52–173 kg
Female Median 65 kg
Range 39–205 kg
Table 2 Detection of obstruction.
Gold standard Investigated
interpretation
S
Morris-FVC Hankison-FVC 1
Morris-FVC Hankison-FEV6
Hankison-FVC Hankison-FEV6
Obstruction is defined as in the Methods section of the manus
‘‘correct’’ diagnosis of obstruction; Investigated interpretation, t
diagnosis.FEV6. These records were not further evaluated,
leaving 63 patients with evaluable spirograms.
Among the 63 patients with evaluable spiro-
grams, Morris-FVC identified 33 obstructed pa-
tients. Of those 33, Hankison-FVC and Hankison-
FEV6 correctly classified 33 and 32 patients,
respectively. However, Hankison-FVC incorrectly
classified 10 additional patients as being ob-
structed; Hankison-FEV6 misclassified 16 additional
patients as being obstructed. The sensitivity and
specificity for identifying Morris-FVC obstruction
was 100% and 67%, respectively, for Hankison-FVC
and 100% and 65% for Hankison-FEV6 (Table 2). If
one utilized the Hankison-FVC rather than the
Morris-FVC as gold standard, Hankison-FEV6 yielded
a sensitivity of 98% and specificity of 70% for
detecting obstruction.
When more generally analyzing the ability to
separate normal from abnormal spirograms, Morris-
FVC identified 43 of the 63 patients as abnormal.
Hankison-FVC and Hankison-FEV6 both correctly
classified all 43 patients; however, an additional 7
and 10 patients, respectively, were classified as
abnormal. The sensitivity for identifying Morris-FVC
abnormality was 100% for both Hankison-FVC and
Hankison-FEV6; the specificity was 65% and 50%,
respectively (Table 3). Utilizing the Hankison-FVC
as gold standard, Hankison-FEV6 yielded a sensitiv-
ity of 100% and specificity of 77% for diagnosing
abnormal spirograms.
Three cases were diagnosed as obstructed by
Hankison-FEV6 but not by Hankison-FVC. They are
displayed in Table 4. In one case, the FEV1/FEV6
ratio is 99.8% of predicted.Discussion
The results of our study show that FEV6 based
interpretation is a sensitive but non-specific meth-
od for the detection of obstruction when performed
on referred patients in a hospital pulmonaryensitivity (%) Specificity (%)
00 67
97 47
98 70
cript. Gold standard, the interpretive strategy yielding the
he interpretative strategy compared to the ‘‘gold standard’’
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Table 3 Detetction of abnormal spirometry.
Gold standard Investigated
interpretation
Sensitivity (%) Specificity (%)
Morris-FVC Hankison-FVC 100 65
Morris-FVC Hankison-FEV6 100 50
Hankison-FVC Hankison-FEV6 100 77
Abnormal spirometry is defined as in the Methods section of the manuscript. Gold standard, the interpretive strategy yielding
the ‘‘correct’’ diagnosis of abnormal spirometry; Investigated interpretation, the interpretative strategy compared to the ‘‘gold
standard’’ diagnosis.
Table 4 Hankison discordant obstruction results—patients who had normal spirometry when analyzed using
Hankison-FVC who had obstruction when analyzed with Hankison-FEV6.
FEV1/FVC
classification
FEV1/FEV6
classification
Sex Age (yr) FEV/FVC (%) FEV1/FEV6 (%) Expiratory
time (s)
Normal Obstructed M 57 104 99.8 6.0
Normal Obstructed M 71 102 96 6.2
Normal Obstructed F 50 101 98 6.0
S. Gleeson et al.1400function laboratory with a diagnostic spirometer.
Our sensitivity ranged from 97% to 100% (depending
on the gold standard used) and is consistent with
work done by Swanney et al.2 who reviewed 337
cases and found that Hankison-FEV6 vs. Hankison-
FVC was 95% sensitive in detecting obstruction. In
contrast, we found that specificity for FEV6 based
calculations to detect obstruction ranged from 47%
to 70%. This is distinct from Swanney who demon-
strated 97.4% specificity for Hankison-FEV6 vs.
Hankison-FVC for detecting obstruction.
As the ATS spirometry criteria state,5 population
characteristics are an important factor in choosing
reference values for the population being evalu-
ated. Our pulmonary function laboratory utilizes
the Morris reference equations based on results
obtained from testing a cohort of normal subjects.
As a first step in our analysis, we compared the
Hankison predictive equations for FEV1 and FVC to
the results we obtained using the Morris predictive
equations. This analysis revealed that the Hankison
predictions were 100% sensitive but only 67%
specific in diagnosing obstructive spirometry. The
Hankison predictive equations were generated
from the third National Health and Nutrition
Examination Survey and included an oversampling
of African-American and Mexican-American popula-
tions. Our population was overwhelmingly Cauca-
sian, and this may explain why the Hankison
equations demonstrated only moderate specificity.
Once we had determined the performance of
Hankison-FVC based analysis, we sought to compare
Hankison-FEV6 based interpretation to our gold
standard Morris-FVC based diagnosis. Hankison-FEV6was very sensitive for obstruction at 100%. However,
the specificity of Hankison-FEV6 for obstruction was
only moderate at 47%. This result was not surprising
given the moderate specificity of Hankison-FVC for
predicting results generated with Morris-FVC.
To further explore the characteristics of Hankison
based FEV6 interpretation in our population of
patients; we compared Hankison-FVC to Hankison-
FEV6 for diagnosing obstruction in our patients.
Using Hankison-FVC as our standard, we classified
43 patients as obstructed. Hankison-FEV6 classified
48 patients as obstructed; 42 overlapped the
Hankison-FVC obstructed patients, and 6 were
normal based on FVC criteria yielding a sensitivity
of 98% and a specificity of 70% for detecting
obstruction. Although the specificity is improved
relative to comparison with our Morris-FVC based
gold standard, it is much lower than the 97.4%
specificity reported by Swanney et al.2 It is not
clear why our results differ from Swanney. Their
study was conducted in New Zealand which may
represent a different population despite the fact
that 100% of their tested population was Caucasian.
Our study evaluated only 63 patients compared to
337 in the Swanney study.
When considering the use of FEV6 based office
spirometers for screening, one can argue that
diagnosing obstruction is not important. Rather,
utilizing a spirometer that can reliably separate
normal from abnormal pulmonary function is
crucial. If screening spirometry is abnormal, pa-
tients can then be referred for formal, full
pulmonary function tests to better characterize
their specific derangements. With that in mind, we
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as normal or abnormal based on our 3 different sets
of predictive equations. For diagnosing abnormal
spirometry using Morris-FVC as the reference,
Hankison-FVC and Hankison-FEV6 exhibited almost
identical performance as when diagnosing obstruc-
tion, demonstrating a high sensitivity and a
moderate specificity. Using Hankison-FVC as the
gold standard, Hankison-FEV6 exhibited good sensi-
tivity and was more specific for the diagnosis of
abnormal spirometry than for the diagnosis of
obstruction (77% vs. 70%). One of the three
discordant cases (normal by Hankison-FVC; abnor-
mal by Hankison-FEV6), had an FEV1/FEV6 ratio of
99.8%. If we consider that to be a normal result, the
specificity of Hankison-FEV6 for predicting abnor-
mal spirometry rises to 83%.
Several other issues are pertinent when consid-
ering the use of FEV6 for screening office spirome-
try. In both Swanney’s and the current study,
trained technicians obtained the spirometry. How-
ever, office spirometry is designed to be conducted
in the primary care setting by less well-trained
operators. Thus its reliability in the office setting
without trained technicians is still unclear.
Thirty-seven percent of our cases did not achieve
an FEV6. This is not surprising since healthy young
adults empty their lungs in less than 6 s, and co-
morbid illnesses and patient fatigue may cause
patients to end expiration prior to 6 s. The ATS
criteria allow the substitution of FVC for FEV6 as an
end of test criterion when expiratory time is less than
6 s providing that the effort is good as demonstrated
by reaching an expiratory plateau. This determina-
tion, however, requires the operator obtaining the
test to achieve a technically good FVC maneuver.
Only 18% of our population expired for longer than
8 s. Forty-five percent of our population expired for a
duration of 6–8 s. We speculate that many of these
patients would not have achieved the 6 s end-of-test
criterion if not encouraged by highly trained respira-
tory personnel.Conclusion
Spirometry based on measurement of FEV6 rather
than FVC has been recommended for screening
smokers in order to encourage smoking cessation.8This study suggests that FEV1/FEV6 (and FEV1/FVC)
interpreted using the predictive equations of
Hankison are a sensitive method for the detection
of obstruction or abnormal pulmonary function
when performed in a hospital pulmonary func-
tion laboratory. However, in our population, FEV1/
FEV6 (and FEV1/FVC) based interpretations are
only moderately specific, potentially leading to
further investigation of a large number of normal
patients.
This study and previous validation work have
been done with a homogeneous population of
primarily Caucasian patients, in standardized set-
tings, using trained personnel to administer and
read the pulmonary function tests. At present,
there is only one set of predictive equations
available to guide interpretation of the FEV6 based
results. Based on this, we believe that further
work should be done to confirm the diagnostic
accuracy of this method of spirogram interpreta-
tion before it can be recommended for general
office screening.References
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